Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

DnaJC5B Inhibitors

DnaJC5B inhibitors constitutes a diverse group of chemical entities that have garnered significant attention due to their potential to interact with and modulate the activity of the DnaJC5B protein. DnaJC5B, also known as CSPα (Cysteine String Protein alpha), is a pivotal member of the DNAJ family of proteins, which act as co-chaperones in conjunction with heat shock proteins (HSPs). DnaJC5B plays a pivotal role in regulating fundamental cellular processes, most notably synaptic vesicle exocytosis, by participating in the formation of SNARE complexes, which are essential for neurotransmitter release. This protein is also implicated in protein folding, trafficking, and the maintenance of cellular protein homeostasis. Inhibiting DnaJC5B involves a sophisticated interplay between the intricate three-dimensional structure of the protein and the chemical properties of the inhibitors. These inhibitors are that bind to distinct regions on DnaJC5B, modulating its function. Mechanistically, these compounds may operate through competitive binding to the substrate-binding domains of DnaJC5B or by disrupting critical protein-protein interactions that facilitate its activity. The goal of these inhibitors is not only to shed light on the protein's functional role but also to unveil potential regulatory mechanisms within cellular processes. The development of DnaJC5B inhibitors necessitates a comprehensive comprehension of the protein's structural attributes, molecular interactions, and involvement in various cellular pathways. In this endeavor, researchers leverage advanced computational modeling, structural biology techniques like X-ray crystallography or NMR spectroscopy, and high-throughput screening methods. The ultimate objective is to create compounds with high selectivity for DnaJC5B, allowing researchers to precisely manipulate its activity and explore its functional implications in cellular contexts.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MLN 4924

905579-51-3sc-484814
1 mg
$280.00
1
(0)

Blocks NEDD8-activating enzyme, leading to cell cycle arrest and apoptosis in cancer cells.

Aclidinium Bromide

320345-99-1sc-480200
100 mg
$388.00
(0)

Acts as a long-acting muscarinic antagonist, studied in the research of chronic obstructive pulmonary disease (COPD).

MK-2206 dihydrochloride

1032350-13-2sc-364537
sc-364537A
5 mg
10 mg
$178.00
$325.00
67
(1)

Akt inhibitor, blocking signaling pathways involved in cancer cell survival and growth.

Ibrutinib

936563-96-1sc-483194
10 mg
$153.00
5
(0)

Covalently binds to BTK, suppressing B-cell signaling and employed in B-cell malignancies like lymphomas.

Erismodegib

956697-53-3sc-396280
sc-396280A
10 mg
100 mg
$255.00
$918.00
(0)

Smoothened inhibitor, blocking the Hedgehog signaling pathway in advanced basal cell carcinoma.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$116.00
$330.00
$510.00
$816.00
$1632.00
10
(0)

Bcl-2 inhibitor, promoting apoptosis in cancer cells.